Hello,
I read this thread with interest.
As per my understanding, broadly diagnostic services are for either indoor patients or outdoor patients.
Indoor patients are usually more sick and hence, have limited choice. Hence, usually they shall utilise in-house hospital diagnostic services only, which provides hospital pricing power.
Outdoor patients will go either on doctor recommendation because of quality or cost/ convenience.
So, KRSNAA is looking at tapping outdoor patients except for government hospitals where it has tie ups.
The problem with central reporting is it’s difficult to create a repo with local physicians and hence, difficult to get physician recommendation and hence, premium charging.
So, essentially, it is going to compete on basis of cost advantage and perhaps ease/ access.
Isn’t is like a D-mart model where one needs to be most cost effective and has ability to cross sell higher margin tests to be able to be a multi beggar.
And as far as I understand, it is still launching basic radiology and pathology services and trying to compete on price.
Thanks
Subscribe To Our Free Newsletter |